
News &
Media
-
Neurotech International is anticipating results from its extended world first study of a medicinal cannabis product in children which could be a game-changer in autism treatment.
Neurotech is anticipating results from its extended world first study of a medicinal cannabis product in children which could be a game-changer in autism treatment. Read the full story here.
-
ASX Small & Mid-Cap Conference: Neurotech International Limited
Executive Director, Dr Tom Duthy presents Neurotech International at the ASX Small and Mid-Cap Conference on the 14th September, 2022. Watch the video recording here.
-
Neurotech International with Proactive at the ASX Small and Mid-Cap Conference
Neurotech International Executive Director Dr Tom Duthy speaks with Proactive at the ASX Small and Mid-Cap Conference September 2022.
-
Cannabis extract has Autism success
-
New Hope for Children Living with Autism. Channel 7 NEWS 28 August 2022
-
Neurotech International appoints industry expert during key phase of growth
Neurotech International has made key appointments and changes to its board as it focuses on its developing and commercialising neurological solutions, including a cannabis breakthrough for paediatric autism.
-
Gerald Quigley, short discussion on 4RO Rockhampton regarding Autism
-
Gerald Quigley, Co-host of The House of Wellness on 6PR discusses exciting new developments in Autism Spectrum Disorder (ASD) field linked to Cannabis, including a particular extract called NTI164.
-
Stocks Down Under Interview with Neurotech International (ASX:NTI)